Epigral Limited informs that the Board of Directors at its meeting held today i.e. 27.01.2025 inter-alia has declared Interim Dividend of Rs. 2.50 (25%) per equity share of face value of Rs. 10/- each for the F. Y. 2024-25.

pdf

Epigral Ltd.

27 Jan 2025

1875.00

-0.70%

Earnings Call

Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Epigral Limited hereby submits Audio Recording of Conference Call held today i.e. 27.01.2025 discussing Q3 FY25 results.

pdf

Epigral Ltd.

27 Jan 2025

1875.00

-0.70%

Company Update

Epigral Ltd - 543332 - Statement Of Deviation Or Variation In Utilization Of The Funds Raised …

BSE India

Epigral Limited submits statement of deviation or variation in utilization of the funds raised through QIP for the quarter ended 31.12.2024

pdf

Epigral Ltd.

27 Jan 2025

1875.00

-0.70%

Company Update

Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

BSE India

Epigral Limited submits Monitoring Agency Report for the quarter ended 31.12.2024

pdf

Epigral Ltd.

27 Jan 2025

1875.00

-0.70%

Epigral Results Earnings Call for Q3FY25

Conference Call with Epigral Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Epigral Ltd.

27 Jan 2025

1875.00

-0.70%

to see Rapid results content

VOTE: Is Meghmani Finechem Ltd. worth buying?

84 Votes:

Buy 86.9%

Sell 9.52%

Hold 3.57%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf